L-Arginine and Its Metabolites in Age-Related Cerebral Small Vessel Disease with Cognitive Impairment
Biomolecules · 19.06.2026 · 16 (6) · 914
DOI: 10.3390/biom16060914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 19.06.2026. Verfasst von Larisa Dobrynina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Russian Center of Neurology and Neurosciences, 125367 Moscow, Russia. Hauptthemen laut MEDLINE: Arginine, Cerebral Small Vessel Diseases, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
A key mechanism in the pathogenesis of cerebral small vessel disease (CSVD) is endothelial dysfunction associated with impaired metabolism of nitric oxide (NO) and its main substrate, L-arginine. The aim of the study was to assess parameters of L-arginine metabolism and their association with MRI-defined brain damage in CSVD patients. A total of 100 CSVD patients (according to MRI STRIVE standards) and cognitive impairment (CI) of varying severity, as well as 20 healthy volunteers, were analyzed. Levels of L-arginine and its metabolites—L-ornithine, L-citrulline, and asymmetric dimethylarginine (ADMA)—were measured; diffusion tensor MRI, MRI volumetry, and morphometry were performed. A threshold level of L-arginine (51.25 μmol/L) was identified, above which an association with CI was observed. Patients with L-arginine ≥ 51.25 μmol/L demonstrated poorer performance on cognitive tests (Stroop test, trail-making test (TMT)-B, TMT B–A, 10-word test) and more severe brain damage, reflected by greater severity of MRI markers (white matter hyperintensities, microbleeds), changes in brain component volumes, cortical atrophy in specific regions, and impairment of white matter microstructural integrity. The obtained data indicate a pathogenetic link between disturbances in L-arginine homeostasis and the development of CSVD with CI and support the need for further studies aimed at refining approaches to their correction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Russian Center of Neurology and Neurosciences, 125367 Moscow, Russia.
ORCID-Profile: Larisa Dobrynina, Elena Kremneva, Maryam Zabitova
Förderung
- Russian Science Foundation
Zitieren
APA
Dobrynina, L., Byrochkina, A., Shamtieva, K., Kremneva, E., Zabitova, M., & Shabalina, A. (2026). L-Arginine and Its Metabolites in Age-Related Cerebral Small Vessel Disease with Cognitive Impairment. Biomolecules, 16(6), 914. https://doi.org/10.3390/biom16060914
Vancouver
Dobrynina L, Byrochkina A, Shamtieva K, Kremneva E, Zabitova M, Shabalina A. L-Arginine and Its Metabolites in Age-Related Cerebral Small Vessel Disease with Cognitive Impairment. Biomolecules. 2026;16(6):914. doi:10.3390/biom16060914
BibTeX
@article{Dobrynina2026,
author = {Dobrynina, Larisa and Byrochkina, Alexandra and Shamtieva, Kamila and Kremneva, Elena and Zabitova, Maryam and Shabalina, Alla},
title = {L-Arginine and Its Metabolites in Age-Related Cerebral Small Vessel Disease with Cognitive Impairment},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {6},
pages = {914},
doi = {10.3390/biom16060914}
}
EUVIMED